DMK Pharmaceuticals Corporation (DMKPQ)
OTCMKTS: DMKPQ · Delayed Price · USD
0.0260
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
DMK Pharmaceuticals Employees
As of December 31, 2022, DMK Pharmaceuticals had 12 total employees, including 11 full-time and 1 part-time employees. The number of employees decreased by 3 or -20.00% compared to the previous year.
Employees
12
Change (1Y)
-3
Growth (1Y)
-20.00%
Revenue / Employee
$301,641
Profits / Employee
-$1,852,718
Market Cap
262.65K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
DMKPQ News
- 6 months ago - DMK Pharmaceuticals Commences Restructuring Proceeding - Newsfile Corp
- 7 months ago - DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI - GlobeNewsWire
- 8 months ago - DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update - GlobeNewsWire
- 8 months ago - DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023 - GlobeNewsWire
- 9 months ago - DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 months ago - DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth - GlobeNewsWire